Indivior's New Suboxone Patent Cannot Keep Dr. Reddy's Generic Off Market

US Federal Circuit applies new standard in finding continuation patent claims are indistinct from those in parent patent, vacates preliminary injunction.

Federal Circuit closeup_683614828_1200.jpg

More from Legal & IP

More from Generics Bulletin